BASF India Ltd

Q3 FY25 Earnings Call Analysis

Chemicals & Petrochemicals

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 4margin: Category 3orderbook: No information
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- On page 12, Mr. Alexander Gerding mentioned a good pipeline of orders in the process catalyst part of the performance chemical segment. - However, some project delays have also delayed delivery and closure of these orders. - The paint industry, important for the dispersant business, had been flat or degrowing over the last 10 years but is now showing positive off-take, indicating potential order growth. - No specific quantitative values or exact current orderbook size were disclosed. - The company is actively evaluating new project opportunities, both organic and inorganic, to strengthen the core chemical business, which implies ongoing and future order prospects.
💰

fundraise

Any current/future new fundraising through debt or equity?

- No specific forward-looking statements on fundraising through debt or equity in India are made at this time. - The company has consistently maintained a healthy and near debt-free position locally. - Globally, the parent company has an active strategy to reduce debt. - While options for improving the business and investing in India are continuously evaluated, there is no current plan for promoter stake sale or similar fundraising in India. - Capital expenditure (Capex) for investments will be considered only if there is a solid business case. - Overall, focus remains on strong financial health with no immediate plans for raising funds through debt or equity in India.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Upgradation of the Cellesto asset at the Hedge location underway, including capacity improvement and a large building to support future growth. (Page 13) - Investments aimed at modernizing lines, increasing automation, improving efficiency, and localizing imports (e.g., parts from Germany) to enhance profitability. (Page 14) - Ongoing evaluation of new project opportunities, both organic and inorganic, to strengthen core chemical businesses. (Page 14) - Continued Capex will be considered in India for attractive business cases despite global Capex expected to be below depreciation until 2028 due to large investments in China. (Page 11) - Investment focus on performance materials segment, engineering plastics, and other strategic areas to increase manufacturing product share in India aligned with growth in automotive and other sectors. (Pages 9, 13)
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Agricultural Solutions business is expected to grow driven by volume recovery in upcoming rabbi season, new product launches, and focus on specialty crops like rice and rubber-based applications (2 and 3 wheelers). - Industrial Solutions segment is projected to grow with expansion in dispersion business, EV-related performance chemicals, and plastic additives despite pricing pressures. - Nutrition and Care segment shows positive momentum with volume and price increases, driven by personal care, skin care, and flavors & fragrances. - Performance Materials segment growth expected to be moderate due to ongoing pricing pressure and overcapacity in upstream chemicals, especially from China. - The company is investing in capacity upgrades (e.g., Cellesto asset upgrade) to increase local manufacturing and serve growing automotive sectors. - Pricing environment remains challenging overall; volume growth is a key focus area. - Continuous portfolio strengthening and innovation in core chemical businesses to drive mid to long-term growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Earnings/profits have been impacted recently by higher input costs and unfavorable product mix, leading to a 27% reduction in PBT before exceptional items for six months compared to last year. - Nutrition and Care segment shows promising growth with a 50% increase in profitability (profits nearly doubled), supported by volume and price increases. - Industrial Solutions segment has stable growth with margin improvements and is expected to earn more than the current 5% EBIT margin. - Agricultural Solutions business remains positive long-term due to global food demand and ongoing innovation, despite short-term volume challenges from weather. - Royalty income may fluctuate based on product mix but not necessarily tied to overall sales growth. - Strategic investments and capacity upgrades (e.g., Celesto) support future volume and sales growth, particularly in automotive rubber segments. - Management focuses on operational efficiencies, cost control, and portfolio mix improvements to enhance profitability. - No forward-looking financial guidance provided, but the outlook is cautiously optimistic with ongoing growth drivers.